APA (7th ed.) Citation

A, B., F, B., & JS, H. (2025). Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: A systematic review and meta-analysis. Frontiers in immunology, 16, 1585556. https://doi.org/10.3389/fimmu.2025.1585556

Chicago Style (17th ed.) Citation

A, Biederstädt, Bassermann F, and Hecker JS. "Allogeneic CAR-engineered Cellular Therapy for Relapsed and Refractory Large B Cell Lymphoma: A Systematic Review and Meta-analysis." Frontiers in Immunology 16 (2025): 1585556. https://doi.org/10.3389/fimmu.2025.1585556.

MLA (9th ed.) Citation

A, Biederstädt, et al. "Allogeneic CAR-engineered Cellular Therapy for Relapsed and Refractory Large B Cell Lymphoma: A Systematic Review and Meta-analysis." Frontiers in Immunology, vol. 16, 2025, p. 1585556, https://doi.org/10.3389/fimmu.2025.1585556.